Related Experiment Videos

The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure

Ariel J Reyes1

  • 1Institute of Cardiovascular Theory, Sotelo 3908, 11700 Montevideo, Uruguay. ajreyes@internet.com.uy

European Journal of Heart Failure
|June 1, 2005
PubMed

Insights

Elevated serum uric acid (UA) in chronic heart failure (CHF) may be beneficial. This study hypothesizes that diuretics, which raise UA, could improve outcomes in CHF patients with left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Nephrology
  • Biochemistry

Background:

  • Patients with chronic heart failure (CHF) frequently exhibit elevated serum uric acid (UA) levels.
  • Reduced renal excretion of UA, influenced by sodium restriction and diuretics, contributes to hyperuricemia in CHF.
  • Worsening cardiac function and increased UA production also play roles in elevated UA in advanced CHF.

Purpose of the Study:

  • To investigate the potential beneficial role of elevated serum uric acid (UA) in chronic heart failure (CHF).
  • To test the hypothesis that diuretic-induced increases in UA may offer protective effects in CHF patients.
  • To explore the impact of add-on thiazide diuretic therapy on morbidity and mortality in asymptomatic CHF patients with left ventricular dysfunction.

Main Methods:

  • Observational analysis of serum uric acid (UA) levels in patients with varying stages of chronic heart failure (CHF).
  • Review of existing literature on the role of diuretics in antihypertensive therapy and heart failure prevention.
  • Proposal for a clinical trial to assess the effects of add-on thiazide diuretic treatment in specific CHF patient cohorts.

Main Results:

  • Serum uric acid (UA) levels are consistently raised in patients with mild-moderate and advanced chronic heart failure (CHF).
  • Diuretics, commonly used in CHF management, are associated with increased serum UA levels.
  • Antihypertensive therapies including diuretics have demonstrated superior efficacy in preventing heart failure development.

Conclusions:

  • Elevated serum uric acid (UA) in chronic heart failure (CHF) may possess antioxidant properties, potentially mitigating oxidative stress.
  • Diuretic-induced hyperuricemia could be a beneficial compensatory mechanism in CHF.
  • Further research via clinical trials is warranted to confirm the therapeutic potential of thiazide diuretics in specific CHF populations.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.